AIMCA
RVMD icon

Alberta Investment Management Corp (AIMCo)’s Revolution Medicines RVMD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,000
Closed -$3.4M – 706
2026
Q1 		$3.4M Buy
+35,000
New +$3.53M 0.02% 352

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
MGB
Mass General Brigham Somerville, Massachusetts $361M AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s RVMD Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 35,000 shares — an estimated $3.4M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in RVMD in Q1 2026 and held it in 1 quarter. The position peaked at $3.4M in Q1 2026. 294 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 35,000 Revolution Medicines shares in Q2 2026, an estimated $3.4M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Revolution Medicines in Q1 2026 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Revolution Medicines position peaked at $3.4M in Q1 2026.
  • 294 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.